Center for Addictive Disorders
The Charles Bronfman Institute for Personalized Medicine is revolutionizing medicine and health care based on your personal DNA and data. Our world-class faculty is leading the way in discovering genetic underpinnings of common diseases and in advancing genome-informed medicine at the Mount Sinai Health System.
Loading...
Meet Our Team
Yasmin Hurd, PhD
Director, Addiction Institute at Mount Sinai
Timothy K Brennan, MD
Director of Addiction Services, AIMS - West/St. Luke's
Annie Levesque, MD
Medical Director, AIMS - West/St. Luke's
Don C Des Jarlais, PhD
Director, Division of Epidemiology and Health Service Research, Mount Sinai Beth Israel
Uraina Clark, PhD
Assistant Professor, Neurology
Vilma Gabbay, MD
Chief, Pediatric Mood and Anxiety Disorders Program
Igor Galynker, MD
Director, Family Center for Bipolar Disorder, Mount Sinai Beth Israel
Rita Z Goldstein, PhD
Chief, Neuropsychoimaging of Addiction and Related Conditions (NARC) Research
Thomas B Hildebrandt, PsyD
Associate Professor of Psychiatry
Iliyan Ivanov, MD
Medical Director, Comprehensive Adolescent Rehabilitation and Education services program, Mount Sinai West
Nelly Alia-Klein, PhD
Co-Chief, Neuropsychoimaging of Addiction and Related Conditions (NARC) Research Program
David Lehman, MD
ASSISTANT PROFESSOR
Andrew N Merling, PhD
ASSISTANT PROFESSOR
ANNA M OPRESCU
Project Manager
David Perlman, MD
Associate Chief, Infectious Diseases, Mount Sinai Beth Israel
Joseph S Ruggiero, PhD
Associate Director, Addiction Treatment Services, Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West
Edwin Salsitz, MD
Medical Director, Division of Chemical Dependency, Mount Sinai Beth Israel
Shilpa R Taufique, PhD
Director, CARES, Child and Family Institute; Director, Education and Training in Child and Adolescent Psychology
Anil A Thomas, MD
ASSISTANT PROFESSOR
Faye Chao, MD
ASSISTANT PROFESSOR
Muhammad Parvaz, PhD
ASSISTANT PROFESSOR
An-Li Wang, PhD
ASSISTANT PROFESSORFeatured Labs
Latest Publications
Judy H. Cho, MD
The Promise of Epigenetics: Has it Delivered New Insights?
The Promise of Epigenetics: Has it Delivered New Insights?
Ron Do, PhD
Rare Variant in Scavenger Receptor BI Raises HDL Cholesterol and Increases Risk of Coronary Heart Disease
Rare Variant in Scavenger Receptor BI Raises HDL Cholesterol and Increases Risk of Coronary Heart Disease
Eimear Kenny, PhD
GBStools: A Statistical Method for Estimating Allelic Dropout in Reduced Representation Sequencing Data
GBStools: A Statistical Method for Estimating Allelic Dropout in Reduced Representation Sequencing Data
Ruth Loos, PhD
Testing the Role of Predicted Gene Knockouts in Human Anthropometric Train Variation
Testing the Role of Predicted Gene Knockouts in Human Anthropometric Train Variation
Girish Nadkarni, MD, MPH
Genomics in CKD: Is This the Path Forward?
Genomics in CKD: Is This the Path Forward?
Aniwaa Owusu Obeng, PharmD
Genetic Variation among 82 Pharmacogenes: The PGRN-Seq Data From the eMERGE Network
Genetic Variation among 82 Pharmacogenes: The PGRN-Seq Data From the eMERGE Network
Stuart Scott
Polygenic Overlap Between Schizophrenia Risk and Antipsychotic Response: A Genomic Medicine Approach
Polygenic Overlap Between Schizophrenia Risk and Antipsychotic Response: A Genomic Medicine Approach
Inga Peter
Mutation Screening of Candidate Genes in Patients With Nonsyndromic Sagittal Craniosynostosis
Mutation Screening of Candidate Genes in Patients With Nonsyndromic Sagittal Craniosynostosis
Loading Tweets...